title: Stop codons and UGG promote efficient binding of the polypeptide release factor eRF1 to the ribosomal A site.
abstract: To investigate the codon dependence of human eRF1 binding to the mRNA-ribosome complex, we examined the formation of photocrosslinks between ribosomal components and mRNAs bearing a photoactivable 4-thiouridine probe in the first position of the codon located in the A site. Addition of eRF1 to the phased mRNA-ribosome complexes triggers a codon-dependent quenching of crosslink formation. The concentration of eRF1 triggering half quenching ranges from low for the three stop codons, to intermediate for s4UGG and high for other near-cognate triplets. A theoretical analysis of the photochemical processes occurring in a two-state bimolecular model raises a number of stringent conditions, fulfilled by the system studied here, and shows that in any case sound KD values can be extracted if the ratio mT/KD<<1 (mT is total concentration of mRNA added). Considering the KD values obtained for the stop, s4UGG and sense codons (approximately 0.06 microM, 0.45 microM and 2.3 microM, respectively) and our previous finding that only the stop and s4UGG codons are able to promote formation of an eRF1-mRNA crosslink, implying a role for the NIKS loop at the tip of the N domain, we propose a two-step model for eRF1 binding to the A site: a codon-independent bimolecular step is followed by an isomerisation step observed solely with stop and s4UGG codons. Full recognition of the stop codons by the N domain of eRF1 triggers a rearrangement of bound eRF1 from an open to a closed conformation, allowing the universally conserved GGQ loop at the tip of the M domain to come into close proximity of the peptidyl transferase center of the ribosome. UGG is expected to behave as a cryptic stop codon, which, owing to imperfect eRF1-codon recognition, does not allow full reorientation of the M domain of eRF1. As far as the physical steps of eRF1 binding to the ribosome are considered, they appear to closely mimic the behaviour of the tRNA/EF-Tu/GTP complex, but clearly eRF1 is endowed with a greater conformational flexibility than tRNA.
authors.affiliation: Institut Jacques Monod, UMR 7592 CNRS-Universités Paris 7-Paris 6, 2 place Jussieu Tour 43, 75251 Paris, France.
authors.forename: Laurent
authors.initials: L
authors.lastname: Chavatte
authors.forename: Ludmila
authors.initials: L
authors.lastname: Frolova
authors.forename: Philippe
authors.initials: P
authors.lastname: Laugâa
authors.forename: Lev
authors.initials: L
authors.lastname: Kisselev
authors.forename: Alain
authors.initials: A
authors.lastname: Favre
mesh_terms: D001483:Base Sequence; D001665:Binding Sites; D018388:Codon, Terminator / Q000235:genetics* / Q000378:metabolism*; D003432:Cross-Linking Reagents; D006801:Humans; D046911:Macromolecular Substances; D008954:Models, Biological; D008970:Molecular Weight; D009841:Oligonucleotides / Q000235:genetics / Q000378:metabolism; D010454:Peptide Termination Factors / Q000378:metabolism*; D011485:Protein Binding; D014176:Protein Biosynthesis; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism*; D012270:Ribosomes / Q000737:chemistry* / Q000378:metabolism*
chemical_list: D018388:Codon, Terminator; D003432:Cross-Linking Reagents; C489002:ETF1 protein, human; D046911:Macromolecular Substances; D009841:Oligonucleotides; D010454:Peptide Termination Factors; D012333:RNA, Messenger